NCT02268968View on ClinicalTrials.gov

Use of Topical Lidocaine to Reduce Pain in Preterm Infants Receiving Nasal CPAP Continuous Positive Airway Pressure

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Other Preterm Infants
Interventions
DRUG

Lidocaine 2% Gel

Lidocaine 2% gel will be applied to nostrils and nasal CPAP prong 5 minutes prior to application of nasal CPAP

Trial Locations (1)

35516

Neonatal Intensive Care Unit, Mansoura University Children Hospital, Al Mansurah

All Listed Sponsors
lead

Mansoura University Children Hospital

OTHER

NCT02268968 - Use of Topical Lidocaine to Reduce Pain in Preterm Infants Receiving Nasal CPAP Continuous Positive Airway Pressure | Biotech Hunter | Biotech Hunter